Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults

NCT ID: NCT06537232

Last Updated: 2025-01-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-04

Study Completion Date

2025-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The primary purpose of this study is to assess changes in epigenetic markers of aging and physiological parameters in overweight older adults consuming a mixed greens-based supplement over a 30-day period in a randomized crossover design.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Investigators will recruit 20 overweight/obese but otherwise healthy participants aged 50-65. Participants will be randomized to consume the greens-based supplement each morning for the first 30 days or second 30 days of the study. Usual diet, physical activity, and sleep patterns will be encouraged and monitored during the duration of the study.

Phlebotomy will be conducted at baseline, 30-day crossover, and 60-day follow-up to assess DNA methylation in peripheral blood mononuclear cells. Visceral and total body fat, stool microbiome composition, and actigraphy will also be assessed.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aging

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Randomized crossover trial
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Delayed supplementation

Participants will consume greens-based supplement for 30 days after living their normal lives (free-living) for 30 days.

Group Type EXPERIMENTAL

Greens-based Supplement

Intervention Type DIETARY_SUPPLEMENT

Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.

Immediate supplementation

Participant will consume greens-based supplement for 30 days after which they will crossover into a free-living/non-supplementation setting for 30 days.

Group Type EXPERIMENTAL

Greens-based Supplement

Intervention Type DIETARY_SUPPLEMENT

Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Greens-based Supplement

Participant will consume one serving of greens-based supplement per day in the morning, for 30 days.

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women of any ethnicity (women must be postmenopausal)
* Body Mass Index \> 30 kg/m\^2
* Low habitual dark green leafy vegetable consumption
* Willing to adhere to study protocol and measures
* Willing to communicate via smartphone technology
* Able to read, write and speak English

Exclusion Criteria

* Overt cardiometabolic diseases such heart attack, stroke, diabetes, insulin resistance and non-alcoholic fatty liver disease, etc.
* Diagnosis of a transient ischemic attack in the 6 months prior to screening
* Diagnosis of cancer within 5 years prior to screening, except for cutaneous basal cell or squamous cell cancer resolved by excision
* Food allergies
Minimum Eligible Age

50 Years

Maximum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Brickhouse Nutrition

UNKNOWN

Sponsor Role collaborator

Auburn University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Andrew Fruge

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

MIchael D Roberts, PhD

Role: PRINCIPAL_INVESTIGATOR

Auburn University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Auburn University

Auburn, Alabama, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

AUBHG 24

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AC-11 Supplement and Biological Aging
NCT05310123 UNKNOWN PHASE2
Sleep and Morning Wellbeing Study
NCT07311434 NOT_YET_RECRUITING NA